We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VAL market cap is 2.75M. The company's latest EPS is GBP -0.0262 and P/E is -1.16.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.86M | -2.98M | -1.64M | -1.67M | -2.6M |
| Net Income | -4.3M | -2.51M | -1.44M | -1.52M | -2.37M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 4.24M | 3.61M | 4.94M | 3.52M | 3.98M |
| Total Liabilities | 1.2M | 1.38M | 183k | 110k | 150k |
| Total Equity | 3.03M | 2.22M | 4.76M | 3.41M | 3.83M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -3.35M | -1.34M | -1.91M | -1.26M | -1.71M |
| Investing | -324k | -250k | -91k | N/A | N/A |
| Financing | 3.35M | 1.21M | 3.85M | 7k | 2.26M |
| Market Cap | 2.75M |
| Price to Earnings Ratio | -1.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.42 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 90.17M |
| Average Volume (1 week) | 853.07k |
| Average Volume (1 Month) | 860.46k |
| 52 Week Change | -68.72% |
| 52 Week High | 14.75 |
| 52 Week Low | 3.05 |
| Spread (Intraday) | 0.1 (3.23%) |
| Company Name | Valirx Plc |
| Address |
stonebridge house london CM22 7BD |
| Website | https://www.valirx.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
